Omega Fund Management, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001637359 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 14, 2020

Total Value: $242M (100.0% shares, 0.0% debt)

Holdings (16)

REPL Replimune Group 21.9%

Value $52.83M Shares 5,323,455 Est. Cost $17.40 Unrealized -14.3%

— Morphic Holding 18.0%

Value $43.59M Shares 2,969,582 Est. Cost $19.82 Unrealized —

GOSS Gossamer Bio 18.0%

Value $43.4M Shares 4,275,726 Est. Cost $20.85 Unrealized -37.4%

ARQT Arcutis Biothereapeutics 10.4%

Value $25.17M Shares 844,680 Est. Cost $26.87 Unrealized 0.0%

— Translate Bio 10.1%

Value $24.3M Shares 2,437,603 Est. Cost $12.65 Unrealized —

IMUX Immunic 3.4%

Value $8.298M Shares 1,371,494 Est. Cost $13.14 Unrealized -38.8%

— Paratek Pharmaceuticals 3.4%

Value $8.191M Shares 2,600,410 Est. Cost $34.18 Unrealized —

— ESSA Pharma 2.8%

Value $6.759M Shares 1,689,848 Est. Cost $3.14 Unrealized —

BEAM Beam Therapeutics 2.3%

Value $5.451M Shares 302,821 Est. Cost $21.73 Unrealized 0.0%

— Cidara Therapeutics 2.1%

Value $4.98M Shares 2,008,150 Est. Cost $5.64 Unrealized —

— FibroGen 1.9%

Value $4.54M Shares 130,646 Est. Cost $27.34 Unrealized —

TRVI Trevi Therapeutics 1.7%

Value $4.157M Shares 1,263,408 Est. Cost $8.61 Unrealized -47.0%

— Prevail Therapeutics 1.4%

Value $3.326M Shares 272,807 Est. Cost $13.20 Unrealized —

— Jounce Therapeutics 1.0%

Value $2.517M Shares 529,965 Est. Cost $21.99 Unrealized —

— ObsEva 1.0%

Value $2.408M Shares 999,364 Est. Cost $9.76 Unrealized —

— Pieris Pharmaceuticals 0.7%

Value $1.712M Shares 750,741 Est. Cost $1.83 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
REPL	Replimune Group	5,323,455	$52.83M	21.9%	$17.40	-14.3%	Common Stock	76029N106
—	Morphic Holding	2,969,582	$43.59M	18.0%	$19.82	—	Common Stock	61775R105
GOSS	Gossamer Bio	4,275,726	$43.4M	18.0%	$20.85	-37.4%	Common Stock	38341P102
ARQT	Arcutis Biothereapeutics	844,680	$25.17M	10.4%	$26.87	0.0%	Common Stock	03969K108
—	Translate Bio	2,437,603	$24.3M	10.1%	$12.65	—	Common Stock	89374L104
IMUX	Immunic	1,371,494	$8.298M	3.4%	$13.14	-38.8%	Common Stock	4525EP101
—	Paratek Pharmaceuticals	2,600,410	$8.191M	3.4%	$34.18	—	Common Stock	699374302
—	ESSA Pharma	1,689,848	$6.759M	2.8%	$3.14	—	Common Stock	29668H708
BEAM	Beam Therapeutics	302,821	$5.451M	2.3%	$21.73	0.0%	Common Stock	07373V105
—	Cidara Therapeutics	2,008,150	$4.98M	2.1%	$5.64	—	Common Stock	171757107
—	FibroGen	130,646	$4.54M	1.9%	$27.34	—	Common Stock	31572Q808
TRVI	Trevi Therapeutics	1,263,408	$4.157M	1.7%	$8.61	-47.0%	Common Stock	89532M101
—	Prevail Therapeutics	272,807	$3.326M	1.4%	$13.20	—	Common Stock	74140Y101
—	Jounce Therapeutics	529,965	$2.517M	1.0%	$21.99	—	Common Stock	481116101
—	ObsEva	999,364	$2.408M	1.0%	$9.76	—	Common Stock	H5861P103
—	Pieris Pharmaceuticals	750,741	$1.712M	0.7%	$1.83	—	Common Stock	720795103